Umesh Muchhal

Person

Monrovia, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 12,152,076
- Issue date Nov 26, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 12,129,309
- Issue date Oct 29, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,945,880
- Issue date Apr 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,859,011
- Issue date Jan 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,673,972
- Issue date Jun 13, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,492,407
- Issue date Nov 8, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterodimeric antibodies that bind ENPP3 and CD3
- Patent number 11,472,890
- Issue date Oct 18, 2022
- Xencor, Inc.
- Rumana Rashid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 11,352,442
- Issue date Jun 7, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 11,312,770
- Issue date Apr 26, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,225,528
- Issue date Jan 18, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,111,315
- Issue date Sep 7, 2021
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 10,913,803
- Issue date Feb 9, 2021
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 10,889,653
- Issue date Jan 12, 2021
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Complement component C5 antibodies
- Patent number 10,752,678
- Issue date Aug 25, 2020
- Allergan, Inc.
- Peter C. Baciu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 10,526,417
- Issue date Jan 7, 2020
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 10,259,887
- Issue date Apr 16, 2019
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding complement component C5 antibodies
- Patent number 9,932,395
- Issue date Apr 3, 2018
- Allergan, Inc.
- Peter C. Baciu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies to CD3 X CD123
- Patent number 9,856,327
- Issue date Jan 2, 2018
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies to CD3 X CD20
- Patent number 9,850,320
- Issue date Dec 26, 2017
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Complement component C5 antibodies
- Patent number 9,701,743
- Issue date Jul 11, 2017
- Allergan, Inc.
- Peter C. Baciu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibodies that target HM1.24
- Patent number 9,040,042
- Issue date May 26, 2015
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibodies that target HM1.24
- Patent number 8,394,374
- Issue date Mar 12, 2013
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TNF-alpha variants proteins for the treatment of TNF-alpha related...
- Patent number 7,244,823
- Issue date Jul 17, 2007
- Xencor
- Bassil I. Dahiyat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein based tumor necrosis factor-receptor variants for the treat...
- Patent number 7,144,987
- Issue date Dec 5, 2006
- Xencor
- Arthur J. Chirino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids and proteins with thioredoxin reductase activity
- Patent number 7,071,307
- Issue date Jul 4, 2006
- Syngenta Participations AG
- Bipin K. Dalmia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMPLEMENT COMPONENT C5 ANTIBODIES
- Publication number 20240279317
- Publication date Aug 22, 2024
- Allergan, Inc.
- Peter C. Baciu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20230365717
- Publication date Nov 16, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3
- Publication number 20230227581
- Publication date Jul 20, 2023
- Xencor, Inc.
- Rumana Rashid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20230041377
- Publication date Feb 9, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20220403049
- Publication date Dec 22, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
- Publication number 20220204624
- Publication date Jun 30, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20220162343
- Publication date May 26, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28
- Publication number 20220135684
- Publication date May 5, 2022
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20220041757
- Publication date Feb 10, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20210102003
- Publication date Apr 8, 2021
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEMENT COMPONENT C5 ANTIBODIES
- Publication number 20210101965
- Publication date Apr 8, 2021
- Allergan, Inc.
- Peter C. BACIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3
- Publication number 20200317814
- Publication date Oct 8, 2020
- Xencor, Inc.
- Rumana Rashid
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20200199251
- Publication date Jun 25, 2020
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20190202938
- Publication date Jul 4, 2019
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20180305465
- Publication date Oct 25, 2018
- AMGEN INC.
- Jennitte Leann Stevens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20180282432
- Publication date Oct 4, 2018
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEMENT COMPONENT C5 ANTIBODIES
- Publication number 20180222969
- Publication date Aug 9, 2018
- Allergan, Inc.
- Peter C. Baciu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20180223000
- Publication date Aug 9, 2018
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEMENT COMPONENT C5 ANTIBODIES
- Publication number 20170306007
- Publication date Oct 26, 2017
- Allergan, Inc.
- Peter C. Baciu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES TO CD3 X CD123
- Publication number 20170081420
- Publication date Mar 23, 2017
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES TO CD3 X CD123
- Publication number 20170081424
- Publication date Mar 23, 2017
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20160355608
- Publication date Dec 8, 2016
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20160229924
- Publication date Aug 11, 2016
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20160215063
- Publication date Jul 28, 2016
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEMENT COMPONENT C5 ANTIBODIES
- Publication number 20150239966
- Publication date Aug 27, 2015
- Xencor, Inc.
- Peter C. Baciu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET HM1.24
- Publication number 20140205605
- Publication date Jul 24, 2014
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Optimized Antibodies that Target HM1.24
- Publication number 20100104557
- Publication date Apr 29, 2010
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET HM1.24
- Publication number 20080219974
- Publication date Sep 11, 2008
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED...
- Publication number 20070207961
- Publication date Sep 6, 2007
- Xencor
- Bassil I Dahiyat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analysis of MHC-peptide binding interactions
- Publication number 20060228758
- Publication date Oct 12, 2006
- Xencor, Inc.
- Umesh S. Muchhal
- G01 - MEASURING TESTING

Umesh Muchhal

Person

Patents Grantslast 30 patents

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Heterodimeric antibodies that bind CD3 and CD38

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Bispecific checkpoint inhibitor antibodies

Heterodimeric antibodies that bind ENPP3 and CD3

Heterodimeric antibodies that bind CD3 and CD38

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Heterodimeric antibodies that bind CD3 and tumor antigens

Complement component C5 antibodies

Heterodimeric antibodies that bind CD3 and CD38

Heterodimeric antibodies that bind CD3 and tumor antigens

Nucleic acids encoding complement component C5 antibodies

Heterodimeric antibodies to CD3 X CD123

Heterodimeric antibodies to CD3 X CD20

Complement component C5 antibodies

Optimized antibodies that target HM1.24

Optimized antibodies that target HM1.24

TNF-alpha variants proteins for the treatment of TNF-alpha related...

Protein based tumor necrosis factor-receptor variants for the treat...

Nucleic acids and proteins with thioredoxin reductase activity

Patents Applicationslast 30 patents

COMPLEMENT COMPONENT C5 ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

COMPLEMENT COMPONENT C5 ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

COMPLEMENT COMPONENT C5 ANTIBODIES

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

COMPLEMENT COMPONENT C5 ANTIBODIES

HETERODIMERIC ANTIBODIES TO CD3 X CD123

HETERODIMERIC ANTIBODIES TO CD3 X CD123

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

COMPLEMENT COMPONENT C5 ANTIBODIES

OPTIMIZED ANTIBODIES THAT TARGET HM1.24

Optimized Antibodies that Target HM1.24

OPTIMIZED ANTIBODIES THAT TARGET HM1.24

TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED...

Analysis of MHC-peptide binding interactions